Cargando…
A missed opportunity – consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient
BACKGROUND: Levetiracetam is a frequently used drug in the therapy of partial onset, myoclonic and generalized tonic-clonic seizures. The main route of elimination is via the kidneys, which eliminate 66% of the unchanged drug as well as 24% as inactive metabolite that stems from enzymatic hydrolysis...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006077/ https://www.ncbi.nlm.nih.gov/pubmed/24739070 http://dx.doi.org/10.1186/1471-2369-15-49 |